Antimicrobial Agents and Chemotherapy · 2005 · 12 citations · 11 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceDrug DiscoveryMedical MicrobiologyAntibacterial PharmacologyAntibacterial ResistanceAntibacterial TherapyAntibiotic ResistanceAntibiotic Resistance MechanismsMultidrug ResistanceActivitiesAntibacterial Drug DevelopmentAntibiotic Therapy For ChlamydiaChlamydia SusceptibilityIntracellular PenetrationMissense MutationsNovel Antibacterial Drug Discovery
Rifalazil, a semisynthetic rifamycin, was shown previously to have exceptional potency against Chlamydia trachomatis (MIC of 0.00025 microg/ml). We therefore tested 250 additional rifamycin derivatives and identified 12 with activities that are eightfold more potent than that of rifalazil. These compounds also showed exceptional activities against rifampin-resistant strains that carry missense mutations in the rpoB gene. The antimicrobial potency and intracellular penetration of these agents suggest their potential in treatment of chlamydial infections.
11
Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase
Elizabeth A. Campbell, Nataliya Korzheva, Arkady Mustaev et al. · Cell · 2001 · 1.5K citations · Full text
Robert J. Suchland, Agnès Bourillon, Érick Denamur et al. · Antimicrobial Agents and Chemotherapy · 2005 · 38 citations · Full text